Not applicableUnknownNCT01187602What this trial is testingShort Non-coding RNA Biomarkers of Predisposition to Ovarian CancerWho this might be right forOvarian Cancer University of Virginia 103
Early research (Phase 1)Study completedNCT02179970What this trial is testingTo Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal CancersWho this might be right forPancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic CCTU- Cancer Theme 26
Very early researchNot Yet RecruitingNCT06887673What this trial is testingLipid Mediators & Cancer: Montelukast, SPM, and AlmondsWho this might be right forColorectal CancerSarcomaBrain Tumors+2 more University of South Florida 56
Large-scale testing (Phase 3)Study completedNCT00003120What this trial is testingS9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in RemissionWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer SWOG Cancer Research Network 308
Testing effectiveness (Phase 2)WithdrawnNCT00369954What this trial is testingGemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or CarboplatinWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00403429What this trial is testingMITO-6: Capecitabine in Platinum Resistant Ovarian CancerWho this might be right forOvarian Cancer National Cancer Institute, Naples 36
Large-scale testing (Phase 3)Looking for participantsNCT07822646What this trial is testingManganese-primed Immunochemotherapy in Patients With Advanced Ovarian CancerWho this might be right forOvarian Cancer Chinese PLA General Hospital 120
Testing effectiveness (Phase 2)Study completedNCT02249013What this trial is testingShort-course HIPEC in Advanced Epithelial Ovarian CancerWho this might be right forOvarian Cancer Professor Fernando Figueira Integral Medicine Institute 15
Early research (Phase 1)Looking for participantsNCT07306559What this trial is testingTest How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)Who this might be right forAdvanced Relapsed or Refractory Germ Cell TumoursAdvanced Relapsed or Refractory Endometrial CancerAdvanced Relapsed or Refractory Ovarian Cancer Boehringer Ingelheim 187
Not applicableActive Not RecruitingNCT00587886What this trial is testingEstrogen, Diet, Genetics and Endometrial CancerWho this might be right forCancerEndometrial CancerOvarian Cancer+2 more Memorial Sloan Kettering Cancer Center 1,315
Testing effectiveness (Phase 2)Study completedNCT00083122What this trial is testingCisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal CancerWho this might be right forRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity CancerStage IIIA Ovarian Epithelial Cancer+7 more National Cancer Institute (NCI) 45
Not applicableUnknownNCT01823731What this trial is testingA Pilot Test for Newly Developed Synoptic Operative Template for Ovarian Cancer (SOTOC): National Cancer Center - Peritoneal Carcinomatosis IndexWho this might be right forOvarian Cancer National Cancer Center, Korea 50
Early research (Phase 1)UnknownNCT05468190What this trial is testingA Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-TWho this might be right forMetastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more Chongqing Precision Biotech Co., Ltd 48
Testing effectiveness (Phase 2)Study completedNCT01711970What this trial is testingA Phase I/II Trial of VB-111 and Paclitaxel for Recurrent Platinum-Resistant Müllerian CancerWho this might be right forPlatinum Resistant Ovarian Cancer Vascular Biogenics Ltd. operating as VBL Therapeutics 38
Not applicableLooking for participantsNCT06817174What this trial is testingOvarian Cancer Radiomics Approach in CT Led EvaluationWho this might be right forOvarian Cancer Imperial College Healthcare NHS Trust 168
Large-scale testing (Phase 3)UnknownNCT01654146What this trial is testingICON8: Weekly Chemotherapy in Ovarian CancerWho this might be right forOvarian Cancer Medical Research Council 1,485
Testing effectiveness (Phase 2)Looking for participantsNCT07186842What this trial is testingA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9Who this might be right forAdvanced Solid Cancers BioNTech SE 245
Large-scale testing (Phase 3)UnknownNCT00715286What this trial is testingNeoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized StudyWho this might be right forOvarian Carcinoma All India Institute of Medical Sciences 180
Not applicableStudy completedNCT02039388What this trial is testingLavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial CarcinomaWho this might be right forOvarian Epithelial CancerCarcinoma in SituOvarian Cancer Medical University of Vienna 701
Testing effectiveness (Phase 2)Study completedNCT00030446What this trial is testingErlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer NCIC Clinical Trials Group 50